Makrovaskuläre Sekundärprävention mit Pioglitazon bei Diabetikern: PROactive Study (PROspective pioglitAzone Clinical Trial in macroVascular Events)

Author: Nitschmann S.  

Publisher: Springer Publishing Company

ISSN: 0020-9554

Source: Der Internist, Vol.48, Iss.1, 2007-01, pp. : 89-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next